Increased incidence of visceral metastases in scottish patients with BRCA1/2-defective ovarian cancer: an extension of the ovarian BRCAness phenotype (Q48229822)
scientific article published on 20 April 2010
Language:
Current Data About Increased incidence of visceral metastases in scottish patients with BRCA1/2-defective ovarian cancer: an extension of the ovarian BRCAness phenotype
(P31) (Q13442814)
(P248)
(P698) 20406939
(P813) Friday, February 9, 2018
(P854) http://europepmc.org/abstract/MED/20406939

(P50) (Q11718282)
(P1545) 15
(P1932) Jan Lubinski
(P248)
(P698) 20406939
(P813) Friday, February 9, 2018

(P304) 2505-2511
(P248)
(P698) 20406939
(P813) Friday, February 9, 2018
(P854) http://europepmc.org/abstract/MED/20406939

(P407) (Q1860)

(P433) 15
(P248)
(P698) 20406939
(P813) Friday, February 9, 2018
(P854) http://europepmc.org/abstract/MED/20406939

(P478) 28
(P248)
(P698) 20406939
(P813) Friday, February 9, 2018
(P854) http://europepmc.org/abstract/MED/20406939

(P577) Tuesday, April 20, 2010
(P248)
(P698) 20406939
(P813) Friday, February 9, 2018
(P854) http://europepmc.org/abstract/MED/20406939

(P921) (Q172341)
(P887)

(Q104053)
(P887)

(P1433) (Q400292)
(P248)
(P698) 20406939
(P813) Friday, February 9, 2018
(P854) http://europepmc.org/abstract/MED/20406939

(P1476) "Increased incidence of visceral metastases in scottish patients with BRCA1/2-defective ovarian cancer: an extension of the ovarian BRCAness phenotype" (language: en)
(P248)
(P698) 20406939
(P813) Friday, February 9, 2018
(P854) http://europepmc.org/abstract/MED/20406939

(P2093) Charlie Gourley
(P1545) 1
(P248)
(P698) 20406939
(P813) Friday, February 9, 2018
(P854) http://europepmc.org/abstract/MED/20406939

Caroline O Michie
(P1545) 2
(P248)
(P698) 20406939
(P813) Friday, February 9, 2018
(P854) http://europepmc.org/abstract/MED/20406939

Patricia Roxburgh
(P1545) 3
(P248)
(P698) 20406939
(P813) Friday, February 9, 2018
(P854) http://europepmc.org/abstract/MED/20406939

Timothy A Yap
(P1545) 4
(P248)
(P698) 20406939
(P813) Friday, February 9, 2018
(P854) http://europepmc.org/abstract/MED/20406939

Sharon Harden
(P1545) 5
(P248)
(P698) 20406939
(P813) Friday, February 9, 2018
(P854) http://europepmc.org/abstract/MED/20406939

Jim Paul
(P1545) 6
(P248)
(P698) 20406939
(P813) Friday, February 9, 2018
(P854) http://europepmc.org/abstract/MED/20406939

Kalpana Ragupathy
(P1545) 7
(P248)
(P698) 20406939
(P813) Friday, February 9, 2018
(P854) http://europepmc.org/abstract/MED/20406939

Radha Todd
(P1545) 8
(P248)
(P698) 20406939
(P813) Friday, February 9, 2018
(P854) http://europepmc.org/abstract/MED/20406939

Russell Petty
(P1545) 9
(P248)
(P698) 20406939
(P813) Friday, February 9, 2018
(P854) http://europepmc.org/abstract/MED/20406939

Nick Reed
(P1545) 10
(P248)
(P698) 20406939
(P813) Friday, February 9, 2018
(P854) http://europepmc.org/abstract/MED/20406939

Richard L Hayward
(P1545) 11
(P248)
(P698) 20406939
(P813) Friday, February 9, 2018
(P854) http://europepmc.org/abstract/MED/20406939

Paul Mitchell
(P1545) 12
(P248)
(P698) 20406939
(P813) Friday, February 9, 2018
(P854) http://europepmc.org/abstract/MED/20406939

Tzyvia Rye
(P1545) 13
(P248)
(P698) 20406939
(P813) Friday, February 9, 2018
(P854) http://europepmc.org/abstract/MED/20406939

Jan H M Schellens
(P1545) 14
(P248)
(P698) 20406939
(P813) Friday, February 9, 2018
(P854) http://europepmc.org/abstract/MED/20406939

James Carmichael
(P1545) 16
(P248)
(P698) 20406939
(P813) Friday, February 9, 2018
(P854) http://europepmc.org/abstract/MED/20406939

Stan B Kaye
(P1545) 17
(P248)
(P698) 20406939
(P813) Friday, February 9, 2018
(P854) http://europepmc.org/abstract/MED/20406939

Melanie Mackean
(P1545) 18
(P248)
(P698) 20406939
(P813) Friday, February 9, 2018
(P854) http://europepmc.org/abstract/MED/20406939

Michelle Ferguson
(P1545) 19
(P248)
(P698) 20406939
(P813) Friday, February 9, 2018
(P854) http://europepmc.org/abstract/MED/20406939

other details
description scientific article published on 20 April 2010

External Links
(P356) 10.1200/JCO.2009.25.1082
(P698) 20406939
(P5875) 43226873